Editorial: MiR-21: A miRaculous Socratic paradox

Cardiovascular Research

Volumn 87, Issue 3, 2010, Pages 397-400

  Da Costa Martins, Paula A ^a,b   De Windt, Leon J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21; APOPTOSIS REGULATORY PROTEIN; MICRORNA; MIRN21 MICRORNA, RAT; PDCD4 PROTEIN, RAT;

APOPTOSIS; EDITORIAL; HEART DISEASE; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; CELL HYPOXIA; CELL PROTECTION; GENETICS; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE; HUMAN; METABOLISM; NOTE; PATHOLOGY; RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; CYTOPROTECTION; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS;

EID: 77954781730     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq196     Document Type: Editorial

References (15)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116: 281-297.
2. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phyloge-netic shadowing and computational identification of human microRNA genes. Cell 2005;120:21-24.
3. Thum T, Catalucci D, Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 2008;79:562-570.
4. da Costa Martins PA, Bourajjaj M, Gladka M, Kortland M, van Oort RJ, Pinto YM et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008;118:1567-1576.
5. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 2010;18:510-525.
6. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13:39-53.
7. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010;87:431-439.
8. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008;378:492-504.
9. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-8707.
10. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
11. Davis BN, Hilyard AC, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008;454:56-61.
12. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984.
13. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007;42:1137-1141.
14. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009;82: 21-29.
15. Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res 2006;70:297-307.